Böcker av Stephanie Green

Ollie Otter's Daily Schedule is the third in its series, Just An Otter Day. Ollie is an otter with a hearing loss. Join Ollie and his mother's listening and spoken language journey as they go about their daily routines. Included is information about performing a daily listening check and tips for helping a young listener develop listening skills during these crucial years of acquiring language.

Charlotte Stopes was the first woman in Scotland to get a university qualification. She devoted her life to studying Shakespeare and the promotion of women in public life. Though Charlotte is largely forgotten, her daughter Marie is well known. Green asserts that Marie's success can only be understood in relation to the achievements of her mother.

This study examines the periodical press in nineteenth-century culture, and considers issues of gender in the development of the press as a powerful political and social medium. The study explores broad questions as they are raised in a range of different kinds of periodicals, from journals to comic magazines.

This new edition of a bestseller provides a nontechnical and thoroughly up-to-date review of methods and issues related to clinical trials. The authors emphasize the importance of proper study design, analysis, and data management and identify the pitfalls inherent in these processes. The book has been restructured with separate chapters and expanded discussions on general clinical trial issues and issues specific to Phases I, II, and III. New sections cover innovations in Phase I designs, randomized Phase II designs, and overcoming the challenges of array data.

The third edition of the bestselling Clinical Trials in Oncology provides a concise, nontechnical, and thoroughly up-to-date review of methods and issues related to cancer clinical trials. The authors emphasize the importance of proper study design, analysis, and data management and identify the pitfalls inherent in these processes. In addition, the book has been restructured to have separate chapters and expanded discussions on general clinical trials issues, and issues specific to Phases I, II, and III. New sections cover innovations in Phase I designs, randomized Phase II designs, and overcoming the challenges of array data. Although this book focuses on cancer trials, the same issues and concepts are important in any clinical setting. As always, the authors use clear, lucid prose and a multitude of real-world examples to convey the principles of successful trials without the need for a strong statistics or mathematics background. Armed with Clinical Trials in Oncology, Third Edition, clinicians and statisticians can avoid the many hazards that can jeopardize the success of a trial.